ScholarMate
客服热线:400-1616-289

A cohort autopsy study defines COVID-19 systemic pathogenesis

Yao, Xiao-Hong; Luo, Tao; Shi, Yu; He, Zhi-Cheng; Tang, Rui; Zhang, Pei-Pei; Cai, Jun; Zhou, Xiang-Dong; Jiang, Dong-Po; Fei, Xiao-Chun; Huang, Xue-Quan; Zhao, Lei; Zhang, Heng; Wu, Hai-Bo; Ren, Yong; Liu, Zhen-Hua; Zhang, Hua-Rong; Chen, Cong; Fu, Wen-Juan; Li, Heng; Xia, Xin-Yi; Chen, Rong; Wang, Yan; Liu, Xin-Dong; Yin, Chang-Lin; Yan, Ze-Xuan; Wang, Juan; Jing, Rui; Li, Tai-Sheng; Li, Wei-Qin; Wang, Chao-Fu; Ding, Yan-Qing; Mao, Qing; Zhang, Ding-Yu; Zhang, Shu-Yang; Ping, Yi-Fang
Science Citation Index Expanded
南方医科大学; 南京大学; 上海交通大学; 浙江大学; 中国医学科学院北京协和医院; 1

摘要

Severe COVID-19 disease caused by SARS-CoV-2 is frequently accompanied by dysfunction of the lungs and extrapulmonary organs. However, the organotropism of SARS-CoV-2 and the port of virus entry for systemic dissemination remain largely unknown. We profiled 26 COVID-19 autopsy cases from four cohorts in Wuhan, China, and determined the systemic distribution of SARS-CoV-2. SARS-CoV-2 was detected in the lungs and multiple extrapulmonary organs of critically ill COVID-19 patients up to 67 days after symptom onset. Based on organotropism and pathological features of the patients, COVID-19 was divided into viral intrapulmonary and systemic subtypes. In patients with systemic viral distribution, SARS-CoV-2 was detected in monocytes, macrophages, and vascular endothelia at blood-air barrier, blood-testis barrier, and filtration barrier. Critically ill patients with long disease duration showed decreased pulmonary cell proliferation, reduced viral RNA, and marked fibrosis in the lungs. Permanent SARS-CoV-2 presence and tissue injuries in the lungs and extrapulmonary organs suggest direct viral invasion as a mechanism of pathogenicity in critically ill patients. SARS-CoV-2 may hijack monocytes, macrophages, and vascular endothelia at physiological barriers as the ports of entry for systemic dissemination. Our study thus delineates systemic pathological features of SARS-CoV-2 infection, which sheds light on the development of novel COVID-19 treatment.

关键词

ACUTE RESPIRATORY SYNDROME SARS-ASSOCIATED CORONAVIRUS IN-SITU HYBRIDIZATION INFECTED MACROPHAGES CYTOKINE STORM LUNG PATHOLOGY SARS-COV-2 DYSFUNCTION